Hope Is Not A Plan: Manufacturing COVID-19 Therapeutics

 
• By Bowman Cox

Duke-Margolis discussion emphasizes biopharma sector must quickly collaborate on manufacturing coronavirus therapeutics likely to be authorized or approved in coming months.

PS2006_Scientists_1268263663_1200.jpg
deciding how to ramp up production won't be easy • Source: Shutterstock

More from Manufacturing

More from Compliance